Drug Shortage Report for OXYTOCIN INJECTION USP

Last updated on 2024-04-10 History
Report ID 174201
Drug Identification Number 00497398
Brand name OXYTOCIN INJECTION USP
Common or Proper name OXYTOCIN INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) OXYTOCIN
Strength(s) 10UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5 x 5mL amp
ATC code H01BB
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-01-04
Estimated end date 2024-06-17
Actual end date
Shortage status Actual shortage
Updated date 2024-04-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2024-04-10 French Compare
v17 2024-04-10 English Compare
v16 2023-12-13 French Compare
v15 2023-12-13 English Compare
v14 2023-10-12 French Compare
v13 2023-10-12 English Compare
v12 2023-08-23 French Compare
v11 2023-08-23 English Compare
v10 2023-07-11 French Compare
v9 2023-07-11 English Compare
v8 2023-04-24 French Compare
v7 2023-04-24 English Compare
v6 2023-01-05 English Compare
v5 2023-01-04 French Compare
v4 2023-01-04 English Compare
v3 2023-01-03 English Compare
v2 2022-11-10 French Compare
v1 2022-11-10 English Compare

Showing 1 to 18 of 18